ArticlePolymers2024
Guanidine Derivatives Leverage the Antibacterial Performance of Bio-Based Polyamide PA56 Fibres.
Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antibacterial and Moisture Transferring Properties of Functionally Integrated Knitted Firefighting Fabrics.Polymers · 2025Article
- Novel guanidine derivatives as mechanistic scaffolds for anticancer agents: synthesis, characterization, DNA-binding, and computational studies.RSC advances · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bacterial damage has significantly impacted humanity, prompting the control of harmful microorganisms and infectious diseases. In this study, antibacterial bio-based PA56 fibres were prepared with high-speed spinning using ethylene-methyl acrylate-glycidyl methacrylate terpolymer (EMA) as the compatibiliser and polypentamethylene guanidine sulphate (PPGS) as the antibacterial agent. The effects of PPGS content on the properties of PA56 draw-textured yarns (DTYs) were investigated. The compatibility between PPGS and PA greatly improved with EMA incorporation. Compared with PA56 fibres, the elongation at break of the sample containing 2.0 wt% EMA and PPGS increased by 25.93%. The inhibition rates of the fibres with 1.0 wt% PPGS against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.